Mayrovitz Harvey N
Medical Education, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, USA.
Cureus. 2021 Nov 22;13(11):e19813. doi: 10.7759/cureus.19813. eCollection 2021 Nov.
Breast cancer-related lymphedema (BCRL) presents as swelling in the arm, hand, trunk, or breast at varying times after completion of breast cancer treatment. Its reported incidence varies widely in part due to its dependence on the type and extent of the treatment, co-present pre-treatment risk factors, and the criteria used to define its presence. Central to this issue is the quantitative measures that are variously used to specify lymphedema thresholds for its detection and tracking over time and during treatment. The goal of this paper is to discuss these issues and the methods available for the non-invasive quantitative assessment of BCRL. Operational principles and advantages and limitations of the various methods and their clinical history of use and effectiveness are discussed.
乳腺癌相关淋巴水肿(BCRL)表现为乳腺癌治疗结束后的不同时间,手臂、手部、躯干或乳房出现肿胀。其报告发病率差异很大,部分原因在于它取决于治疗的类型和范围、同时存在的治疗前风险因素以及用于定义其存在的标准。该问题的核心是各种用于确定淋巴水肿阈值以随时间和治疗过程进行检测和追踪的定量测量方法。本文的目的是讨论这些问题以及可用于BCRL无创定量评估的方法。讨论了各种方法的操作原理、优缺点及其临床使用历史和有效性。